Navigation Links
Hormones Boost Frequency of Women's Migraine With Aura
Date:12/22/2008

Mouse study finds 2 genes likely behind spread of depression with these headaches

MONDAY, Dec. 22 (HealthDay News) -- In women, hormones increase the frequency of an inherited form of severe migraine accompanied by visual disturbances called auras, according to a Massachusetts General Hospital study.

Like other types of migraine, familial hemiplegic migraine affects women more than men. Most cases of familial hemiplegic migraine are caused by mutations in the CACNA1A gene. However, it hasn't been clear whether these mutations lead to spreading depression -- the event in the brain that suppresses nerve cell activity and has been linked to non-genetic forms of migraine with aura, according to background information in the study.

The study authors found that mice expressing either one or two different CACNA1A mutations that lead to familial hemiplegic migraine in humans had increased susceptibility to spreading depression. The mutation associated with more severe familial hemiplegic migraine caused a greater increase in susceptibility to spreading depression than the mutation linked to a milder form of familial hemiplegic migraine.

Female mice were more likely to have spreading depression than male mice, but this difference was reversed if the female mice had their ovaries removed and then partially restored by replacement of the hormone estrogen.

The researchers concluded that both genetic and hormonal factors affect a person's susceptibility to migraines with aura.

The study was published in the current issue of the Journal of Clinical Investigation.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about migraine headaches.



-- Robert Preidt




'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Fat-Sensing Hormones Might Fight Obesity
2. Hormones May Be to Blame for Womens Cavity Rates
3. Breast Cancer Action Targets Yoplait in Think Before You Pink Campaign; Calls for Yogurt Without Artificial Hormones
4. Age alone should not be used to determine whether to treat prostate cancer with hormones
5. Menopause: Hot Flashes Can Be Reduced 90% without Hormones
6. Patients, Doctors, Pharmacists Praise Bipartisan House Resolution on Compounded Hormones Containing Estriol
7. ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more
8. Heart Hormones Beat Back Cancers in Mice
9. Sex Hormones Dont Seem to Affect Prostate Cancer Risk
10. FDA Asserts New Policy to Restrict Womens Access to Bioidentical Hormones
11. Experts call for better research into link between womens hormones and mood disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormones Boost Frequency of Women's Migraine With Aura
(Date:9/2/2014)... Boston, MA (PRWEB) September 02, 2014 ... normal for everyone. But sometimes the onset of irritability, ... serious condition, reports the September 2014 Harvard Health ... in response to everyday stresses. If they occur for ... functioning, it's an indication to seek help," says Dr. ...
(Date:9/2/2014)... The global market for peripheral vascular ... 2020, growing at an estimated CAGR of 7.2% from ... Grand View Research, Inc. Peripheral vascular devices such as ... used for treating peripheral arterial or coronary arterial diseases ... arteries. These devices are used to decrease the interference ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Researchers in New ... who developed mesothelioma after being exposed to asbestos-contaminated work clothes ... all the details of the report in a new article. ... at the ESI Model Hospital say their patient was ... breathlessness. Further investigation found that she had come in contact ...
(Date:9/2/2014)... Colo. (PRWEB) September 02, 2014 MyRounding, ... patient care, has been selected from a group of ... of the 2014 PrIME Digital Health Challenge. The competition ... one another, Tuesday, Sept. 9th at the CSU Denver ... 2012, MyRounding is based in Denver, Colo. The cloud-based, ...
(Date:9/2/2014)... 02, 2014 Eric Jimenez and Leah ... , a revolutionary makeup application device. Designed to improve ... innovation in the palm of women’s hands to help ... to Color Me’s success lies in its patented technology. ... rate of 15,000 pulses per minute, the device applies ...
Breaking Medicine News(10 mins):Health News:When a Mood Swing Signals Trouble, From the September 2014 Harvard Health Letter 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5Health News:New Report Illustrates That Even Brief Asbestos Exposure Can Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:MyRounding Selected for Digital Health Venture Showcase Finals Top Three Startups Awarded $50,000 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 3
... , SCHAUMBURG, Ill., July 29 The American ... on Cancer (IARC) for its re-categorization of indoor tanning devices ... the highest cancer risk category afforded by this international agency, ... , , "The American Academy of ...
... advisory panel outlines priorities for a fall flu shot rollout ... are pregnant, children six months and older, and health ... swine flu vaccine arrives this fall, a U.S. government advisory ... first-line recipients are parents and caregivers of infants; non-elderly adults ...
... , , , ... ESRX ) announced second quarter net income from continuing operations ... items in the quarter, primarily related to the previously announced acquisition ... was $0.88, up 16% from $0.76 for the same period last ...
... , , ARMONK, N.Y., July 29 ... that St. Elizabeth Healthcare is connecting hospitals, clinics and ... records to improve patient care and lower costs. , , ... Today, only 1.5 percent of U.S. hospital systems have a comprehensive ...
... ARLINGTON, Va., July 29 In response to ... and services (durable medical equipment) and about the Medicare competitive ... has developed a "Myth vs. Reality" list to set the ... Association for Homecare urges members of the media to consider ...
... cancer patients, experts say , WEDNESDAY, July 29 (HealthDay News) ... genomes has been completed by U.S. scientists, who said this ... of blood cancer and advance efforts to develop new therapies. ... samples was conducted as part of the Multiple Myeloma Genomics ...
Cached Medicine News:Health News:American Academy of Dermatology Commends Reclassification of Tanning Beds as Carcinogenic 2Health News:American Academy of Dermatology Commends Reclassification of Tanning Beds as Carcinogenic 3Health News:Pregnant Women, Health-Care Workers Top Swine Flu Vaccine Candidates 2Health News:Express Scripts Reports Strong Second Quarter Earnings 2Health News:Express Scripts Reports Strong Second Quarter Earnings 3Health News:Express Scripts Reports Strong Second Quarter Earnings 4Health News:Express Scripts Reports Strong Second Quarter Earnings 5Health News:Express Scripts Reports Strong Second Quarter Earnings 6Health News:Express Scripts Reports Strong Second Quarter Earnings 7Health News:Express Scripts Reports Strong Second Quarter Earnings 8Health News:Express Scripts Reports Strong Second Quarter Earnings 9Health News:Express Scripts Reports Strong Second Quarter Earnings 10Health News:Express Scripts Reports Strong Second Quarter Earnings 11Health News:Express Scripts Reports Strong Second Quarter Earnings 12Health News:Express Scripts Reports Strong Second Quarter Earnings 13Health News:Express Scripts Reports Strong Second Quarter Earnings 14Health News:St. Elizabeth Healthcare Drives Kentucky's Largest Electronic Medical Records Initiative With IBM 2Health News:St. Elizabeth Healthcare Drives Kentucky's Largest Electronic Medical Records Initiative With IBM 3Health News:American Association for Homecare Sets the Record Straight About Recent Home Medical Equipment Issues in the News 2Health News:American Association for Homecare Sets the Record Straight About Recent Home Medical Equipment Issues in the News 3Health News:Multiple Myeloma Genome Unlocked 2
(Date:9/2/2014)... Israel , September 2, 2014 ... (TASE, NASDAQ: EMITF ) announced today following ... Medical Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M), a subsidiary ... on a fully diluted basis, announced that on September ... holds approximately 30.8% of the voting power ("Gamida Cell") ...
(Date:9/2/2014)... Bluegrass Vascular Technologies (BVT), ... lifesaving devices and methods for vascular access procedures, ... Niederauer , a seasoned senior medical device executive, ... of Series A financing, BVT is focused on ... Catheter System, a proprietary system that allows physicians ...
(Date:9/2/2014)... SOUTH SAN FRANCISCO, Calif. , Sept. 2, 2014 /PRNewswire/ ... announced that Bonnie H. Anderson , president and chief ... at the Morgan Stanley Global Healthcare Unplugged Conference 2014 on ... New York . The live audio ... website at http://investor.veracyte.com . Please connect to the website ...
Breaking Medicine Technology:Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 3Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO 2Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014 2
... Stereotaxis, Inc. (Nasdaq: STXS ) announced today ... million credit facility, which includes a $30 million revolving facility ... term loan that matures on December 31, 2013.  The new ... Company,s previous facility that was scheduled to mature in March ...
... TARRYTOWN, N.Y. and BERLIN, Dec. 20, 2010 Regeneron ... HealthCare today announced positive top-line results for VEGF Trap-Eye ... led by Regeneron, the first of two Phase 3 ... retinal vein occlusion (CRVO).  In this trial, 56.1 percent ...
Cached Medicine Technology:Stereotaxis Completes $40 Million Credit Facility 2Stereotaxis Completes $40 Million Credit Facility 3Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) 2Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) 3Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) 4Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) 5Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) 6Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) 7Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) 8Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME) 9
... The SureStep™ Drug Screen Tests are ... assay for MDMA (Ecstasy). Designed using Microgenics ... is the only point of care immunoassay ... affinity for both MDA and MDEA but ...
... The SureStep™ Drug Screen Tests are ... assay for MDMA (Ecstasy). Designed using Microgenics ... is the only point of care immunoassay ... affinity for both MDA and MDEA but ...
AccuSign® DOA Series Opiates Test...
... The SureStep™ Drug Screen Tests are available ... for MDMA (Ecstasy). Designed using Microgenics Antibody ... the only point of care immunoassay targeted ... for both MDA and MDEA but no ...
Medicine Products: